-
Sisram Medical (01696) retail IPO 16.6x over-subscribed
Sisram Medical (01696) said its retail offering
was over-subscribed by about 16.58 times and the international offering was moderately 
over-subscribed.
  The offer price has been determined at HK$8.88 per share, the lower end of the 
indicative price range of HK$8.88 to HK$12.35. The estimated net proceeds amount to about
HK$688.7 million.
  Dealings in shares on the Main Board are expected to commence tomorrow morning, with a 
board lot size of 400 shares each.
  Sisram Medical is a leading global provider of energy-based medical aesthetic treatment
systems, with comprehensive in-house capability to design, develop and produce such
systems, which often feature its innovative and proprietary technologies.  The listing of
the Group constitutes a spin-off of the Group from Fosun International (00656) and Fosun 
Pharma (02196).

Comments

Post a Comment

Popular posts from this blog

-
CLSA lowers Beijing Ent Water (00371) to HK$6   CLSA cut its target price for Beijing Enterprises Water (BEW)(00371) by 8% to HK$6, and reiterated its "buy" rating.   The research house said BEW's share price has dropped 14% in the last two trading days. First, the 2017 earnings results are below expectations. Second, management is guiding for 20-25% net profit growth for 2018, versus 30% in the past few years. Management now has a cautious approach to water PPP (public-private partnership) projects, which is not  necessarily bad.   CLSA cut its 2018-19 earnings forecasts by 19%. At the current level, it believes many  of the negatives are already priced-in.
Read more
-
HSBC HOLDINGS Appoints Malaysia CEO as Asia-Pacific One-Belt-One-Road Biz Manager  HSBC HOLDINGS(00005.HK)    +1.150 (+1.574%)    Short selling $311.30M; Ratio 15.773%   announced that Malaysia CEO Mukhtar Hussain was appointed to the newly created position of head of Belt and Road initiative in Asia Pacific, effective from 1 July.
Read more
-
Image
WKK INTL (HOLD) (00532.HK)    +0.100 (+15.152%)      announced the results for its subsidiary, Taiwan Kong King, for the nine months ended September 2014. The unaudited combined after-tax net profit decreased 30.26% to $12.239 million, compared with the same period last year. Revenue amounted to $177 million.
Read more